Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium

World News: . []

SALT LAKE CITY Dec 07 2018 GLOBE NEWSWIRE -- Myriad Genetics, Inc NASDAQ MYGN a global leader in personalized medicine today announced that new data on its EndoPredict test will be presented by academic collaborators at the San Antonio Breast ...

More news and information about Myriad Genetics, Inc.

Published By:

Globe Newswire: 13:30 GMT Friday 7th December 2018

Published: .

Search for other references to "myriad" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us